poisar

Stocks · News reference

Beckman Coulter Diagnostics Receives FDA Clearance for Access MeMed BV® Assay

Fiscal.ai

Beckman Coulter Diagnostics, a Danaher company, has received U.S. FDA clearance for its Access MeMed BV® assay, a blood test designed to help clinicians distinguish between bacterial and viral infections.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading